In this study, we found that ZEB1 nuclear translocation was sufficient to decrease miR‐203 expression, this new action as a suitable alternative for targeting survivin‐activated TGF‐β1/Smad signalling in fructose‐driven EMT and liver fibrosis. The gene discussed is TGFB1; the disease is Hepatic fibrosis.